Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. — Natural Product Compound Library | Innovative Drug Discovery | Spectral Intelligence | Micro-ED Analysis

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. Healthy Roots Biotechnology (Shenzhen) Co., Limited Joint Development

中文 EN

Home

Products

NP Database

Services

Tech Insights

About

Contact

中文 EN

Plant Sources

Structural Classes

Microbial Sources

Flagship Varieties

Synthetic Compounds

CAS No.	NAME	Molecular Formula	Molecular Weight	Purity	Price	2D Structure
1075237-97-6	4-(1,3-Dihydroxypropan-2-yl)-6-methoxypyrido[2,3-b]pyrazin-3(4H)-one COC1=NC2=C(C=C1)N=CC(=O)N2C(CO)CO	C₁₁H₁₃N₃O₄	251.24	98%	Click to inquire
1077628-67-1	1-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)thiourea CC1=CN(C=N1)C2=C(C=C(C=C2)NC(=S)N)OC	C₁₂H₁₄N₄OS	262.33	98%	Click to inquire
1079843-60-9	tert-Butyl (3-(5-(2,5-difluorophenyl)-3-(methoxy(methyl)carbamoyl)-2-phenyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)propyl)carbamate CC(C)(C)OC(=O)NCCCC1(N(N=C(S1)C2=C(C=CC(=C2)F)F)C(=O)N(C)OC)C3=CC=CC=C3	C₂₅H₃₀F₂N₄O₄S	520.6	98%	Click to inquire
1080645-95-9	Tirbanibulin mesylate CS(=O)(=O)O.C1COCCN1CCOC2=CC=C(C=C2)C3=CN=C(C=C3)CC(=O)NCC4=CC=CC=C4	C₂₇H₃₃N₃O₆S	527.6	99%	Click to inquire
1081-71-6	Vanilpyruvic acid COC1=C(C=CC(=C1)CC(=O)C(=O)O)O	C₁₀H₁₀O₅	210.18	95%	Click to inquire
108212-75-5	S-[(2R,3S,4S,6S)-6-[[(2R,3S,4S,5R,6R)-5-[(2S,4S,5S)-5-(ethylamino)-4-methoxyoxan-2-yl]oxy-4-hydroxy-6-[[(2S,5Z,9R,13Z)-9-hydroxy-12-(methoxycarbonylamino)-13-[2-(methyltrisulfanyl)ethylidene]-11-oxo-2-bicyclo[7.3.1]trideca-1(12),5-dien-3,7-diynyl]oxy]-2-methyloxan-3-yl]amino]oxy-4-hydroxy-2-methyloxan-3-yl] 4-[(2S,3R,4R,5S,6S)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy-5-iodo-2,3-dimethoxy-6-methylbenzenecarbothioate CCNC1COC(CC1OC)OC2C(C(C(OC2OC3C#CC=CC#CC4(CC(=O)C(=C3C4=CCSSSC)NC(=O)OC)O)C)NOC5CC(C(C(O5)C)SC(=O)C6=C(C(=C(C(=C6OC)OC)OC7C(C(C(C(O7)C)O)OC)O)I)C)O)O	C₅₅H₇₄IN₃O₂₁S₄	1368.4	98%	Click to inquire
108212-76-6	N-Acetyl-Calicheamicin CCN(C1COC(CC1OC)OC2C(C(C(OC2OC3C#CC=CC#CC4(CC(=O)C(=C3C4=CCSSSC)NC(=O)OC)O)C)NOC5CC(C(C(O5)C)SC(=O)C6=C(C(=C(C(=C6OC)OC)OC7C(C(C(C(O7)C)O)OC)O)I)C)O)O)C(=O)C	C₅₇H₇₆IN₃O₂₂S₄	1410.4	98%	Click to inquire
1082525-64-1	1-(Tetrahydro-2H-pyran-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole B1(OC(C(O1)(C)C)(C)C)C2=CC3=C(C=C2)N(N=C3)C4CCCCO4	C₁₈H₂₅BN₂O₃	328.2	98%	Click to inquire
1082743-69-8	rel-6-((3R,4R)-1-benzyl-4-methylpyrrolidin-3-yl)-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one CC1CN(CC1C2=NC3=C(C=NN3C4CCOCC4)C(=O)N2)CC5=CC=CC=C5	C₂₂H₂₇N₅O₂	393.5	98%	Click to inquire
1082743-70-1	PDE-9 inhibitor CC1CN(CC1C2=NC3=C(C=NN3C4CCOCC4)C(=O)N2)CC5=CC=CC=C5	C₂₂H₂₇N₅O₂	393.5	99%	Click to inquire

4-(1,3-Dihydroxypropan-2-yl)-6-methoxypyrido[2,3-b]pyrazin-3(4H)-one

beta-lactamase-IN-1

C₁₁H₁₃N₃O₄ 251.24

1-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)thiourea

1-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)thiourea

C₁₂H₁₄N₄OS 262.33

tert-Butyl (3-(5-(2,5-difluorophenyl)-3-(methoxy(methyl)carbamoyl)-2-phenyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)propyl)carbamate

Carbamic acid, N-[3-[5-(2,5-difluorophenyl)-2,3-dihydro-3-[(methoxymethylamino)carbonyl]-2-phenyl-1,3,4-thiadiazol-2-yl]propyl]-

C₂₅H₃₀F₂N₄O₄S 520.6

Tirbanibulin mesylate

KX2-391 (Mesylate)

C₂₇H₃₃N₃O₆S 527.6

Vanilpyruvic acid

4-Hydroxy-3-Methoxyphenylpyruvic Acid

C₁₀H₁₀O₅ 210.18

S-[(2R,3S,4S,6S)-6-[[(2R,3S,4S,5R,6R)-5-[(2S,4S,5S)-5-(ethylamino)-4-methoxyoxan-2-yl]oxy-4-hydroxy-6-[[(2S,5Z,9R,13Z)-9-hydroxy-12-(methoxycarbonylamino)-13-[2-(methyltrisulfanyl)ethylidene]-11-oxo-2-bicyclo[7.3.1]trideca-1(12),5-dien-3,7-diynyl]oxy]-2-methyloxan-3-yl]amino]oxy-4-hydroxy-2-methyloxan-3-yl] 4-[(2S,3R,4R,5S,6S)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy-5-iodo-2,3-dimethoxy-6-methylbenzenecarbothioate

CALICHEAMICIN GAMMA(1)I

C₅₅H₇₄IN₃O₂₁S₄ 1368.4

N-Acetyl-Calicheamicin

N-Acetyl-Calicheamicin

C₅₇H₇₆IN₃O₂₂S₄ 1410.4

1-(Tetrahydro-2H-pyran-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole

1H-Indazole, 1-(tetrahydro-2H-pyran-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-

C₁₈H₂₅BN₂O₃ 328.2

rel-6-((3R,4R)-1-benzyl-4-methylpyrrolidin-3-yl)-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one

4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1,5-dihydro-6-[(3R,4R)-4-methyl-1-(phenylmethyl)-3-pyrrolidinyl]-1-(tetrahydro-2H-pyran-4-yl)

C₂₂H₂₇N₅O₂ 393.5

PDE-9 inhibitor

PDE-9 inhibitor

C₂₂H₂₇N₅O₂ 393.5

< Previous 1 2 3 4 5 6 7 8 9 10 ... (Current page 15128) 16106 Next >

All products and services are for scientific research only. They may not be used for human administration, nor are they supplied to individual consumers.

Address: Room B410, Virtual University Park Key Laboratory Building, No. 1 Yuexing 2nd Road, High-Tech Zone Community, Yuehai Subdistrict, Nanshan District, Shenzhen

Phone: 400-856-5689

Email: kehuaai@kehuaai.com

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd.

ICP Record No.: 粤ICP备2024241782号